Innovative Medical (China) Probability of Future Stock Price Finishing Under 9.49

002173 Stock   8.09  0.55  6.37%   
Innovative Medical's future price is the expected price of Innovative Medical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Innovative Medical Management performance during a given time horizon utilizing its historical volatility. Check out Innovative Medical Backtesting, Innovative Medical Valuation, Innovative Medical Correlation, Innovative Medical Hype Analysis, Innovative Medical Volatility, Innovative Medical History as well as Innovative Medical Performance.
  
Please specify Innovative Medical's target price for which you would like Innovative Medical odds to be computed.

Innovative Medical Target Price Odds to finish below 9.49

The tendency of Innovative Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under  9.49  after 90 days
 8.09 90 days 9.49 
under 95
Based on a normal probability distribution, the odds of Innovative Medical to stay under  9.49  after 90 days from now is under 95 (This Innovative Medical Management probability density function shows the probability of Innovative Stock to fall within a particular range of prices over 90 days) . Probability of Innovative Medical price to stay between its current price of  8.09  and  9.49  at the end of the 90-day period is about 23.18 .
Assuming the 90 days trading horizon Innovative Medical Management has a beta of -0.16. This suggests as returns on the benchmark increase, returns on holding Innovative Medical are expected to decrease at a much lower rate. During a bear market, however, Innovative Medical Management is likely to outperform the market. Additionally Innovative Medical Management has an alpha of 0.5653, implying that it can generate a 0.57 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Innovative Medical Price Density   
       Price  

Predictive Modules for Innovative Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Innovative Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
3.807.9712.14
Details
Intrinsic
Valuation
LowRealHigh
2.646.8110.98
Details
Naive
Forecast
LowNextHigh
2.506.6610.83
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Innovative Medical. Your research has to be compared to or analyzed against Innovative Medical's peers to derive any actionable benefits. When done correctly, Innovative Medical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Innovative Medical.

Innovative Medical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Innovative Medical is not an exception. The market had few large corrections towards the Innovative Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Innovative Medical Management, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Innovative Medical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.57
β
Beta against Dow Jones-0.16
σ
Overall volatility
1.34
Ir
Information ratio 0.12

Innovative Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Innovative Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Innovative Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Innovative Medical appears to be risky and price may revert if volatility continues
The company reported the revenue of 805.59 M. Net Loss for the year was (34.29 M) with profit before overhead, payroll, taxes, and interest of 46.16 M.
About 42.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: ICU Medical to Present at UBS Global Healthcare Conference in November 2024 ICUI Stock News - StockTitan

Innovative Medical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Innovative Stock often depends not only on the future outlook of the current and potential Innovative Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Innovative Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding449 M

Innovative Medical Technical Analysis

Innovative Medical's future price can be derived by breaking down and analyzing its technical indicators over time. Innovative Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Innovative Medical Management. In general, you should focus on analyzing Innovative Stock price patterns and their correlations with different microeconomic environments and drivers.

Innovative Medical Predictive Forecast Models

Innovative Medical's time-series forecasting models is one of many Innovative Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Innovative Medical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Innovative Medical

Checking the ongoing alerts about Innovative Medical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Innovative Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Innovative Medical appears to be risky and price may revert if volatility continues
The company reported the revenue of 805.59 M. Net Loss for the year was (34.29 M) with profit before overhead, payroll, taxes, and interest of 46.16 M.
About 42.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: ICU Medical to Present at UBS Global Healthcare Conference in November 2024 ICUI Stock News - StockTitan

Other Information on Investing in Innovative Stock

Innovative Medical financial ratios help investors to determine whether Innovative Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Innovative with respect to the benefits of owning Innovative Medical security.